Clinical Scorecard: Stimulating Antitumor Immunity in Patients with Multiple Chronic Conditions: A Proposal Integrating Cryoablation-Induced Immunogenic Cell Death and Multi-Target Traditional Chinese Medicine

At a Glance

Key Highlights

• Combination of cryoablation and Traditional Chinese Medicine enhances antitumor immunity.
• Target the inflammatory milieu shared by cancer and comorbidities.
• Proposal includes a three-phase Tumour Green Therapy framework.
• Focus on minimizing treatment burden while maintaining quality of life.
• Hypothesis requires validation.

Guideline-Based Recommendations

Diagnosis

• Characterize the host's immunological phenotype.

Management

• Implement a stage-adapted sequence of cryoablation and Traditional Chinese Medicine.

Monitoring & Follow-up

• Use biomarkers like neutrophil-to-lymphocyte ratio and CRP to assess treatment effects.

Risks

• Consider herb-drug interactions and product quality.

Patient & Prescribing Data

Older adults with cancer and chronic conditions.

Minimally invasive approaches may be better tolerated than radical treatments.

Clinical Best Practices

• Adopt a holistic view of the patient, considering both cancer and comorbidities.
• Utilize a gentle and sustainable approach to disease control.
• Integrate artificial intelligence for TCM syndrome differentiation.

Related Resources & Content

• International Agency for Research on Cancer